AS

Anirban Sannigrahi

Active Director Director DIN 07886669
DIN 07886669 First appointment Apr 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Anirban Sannigrahi

Data last updated:

Anirban Sannigrahi is a Director at R.B. Pharma Private Limited (since 2018). The company operates in Pharma. R.B. Pharma Private Limited reported revenue of ₹10.47 Cr (FY 2025).

DIN 07886669
Primary Designation Director
Industry Pharma
First Appointment 11 Apr 2018
Oldest Company Age 29 yrs
Largest company R.B. Pharma Private Limited · ₹10.47 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
R.B. Pharma Private Limited U24232WB1997PTC084719
Director11 Apr 20181997₹10.47 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
R.B. Pharma Private Limited
Premium access

Shareholding and investment profile for Anirban Sannigrahi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anirban Sannigrahi

Anirban Sannigrahi currently holds 1 directorship: R.B. Pharma Private Limited (Director, since 11 Apr 2018, revenue ₹10.47 Cr (FY 2025)).

Anirban Sannigrahi was first appointed on 11 Apr 2018 as Director at R.B. Pharma Private Limited.

The current boards of Anirban Sannigrahi's companies include Amrita Sannigrahi (R.B. Pharma Private Limited), Animesh Sannigrahi (R.B. Pharma Private Limited), Anwesha Sannigrahi (R.B. Pharma Private Limited), Asoke Sannigrahi (R.B. Pharma Private Limited), Bulbul Sannigrahi (R.B. Pharma Private Limited), Rina Sannigrahi (R.B. Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available